European Pharmaceutical Review
APRIL 10, 2025
Key findings for UK clinical trials For clinical trials submitted between 2019 and 2023, highlights from the analysis showed that one in eight trials tested treatments in humans for the first time.
European Pharmaceutical Review
AUGUST 23, 2022
The researchers studied 254 VA patients who were diagnosed with PTSD and hepatitis C between October 1999 and September 2019. Many people have PTSD, but there [are] few effective pharmacologic treatments and limited drug development for PTSD,” commented Gradus. The findings are to be published in the American Journal of Epidemiology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 11, 2023
Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities. 2019 ;42:385-406. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. Internet] Nature Portfolio. Antiviral agents.
Pharmaceutical Technology
FEBRUARY 8, 2023
Xu gave the example of the FDA’s first approval of an AAV-based gene therapy for paediatric spinal muscular atrophy patients in 2019, saying that evidence of effectiveness generated from two single-arm externally controlled clinical trials in patients with infantile onset SMA was substantial enough for an approval.
Pharmaceutical Representative Training
JANUARY 30, 2025
For sales representatives, the PRC and CSPP certifications can enhance this understanding and communication with HCPs: Pharmaceutical Representative Certification (PRC) : This certification provides professionals with a foundational knowledge of pharmacology, regulatory standards, and effective communication strategies. link] Rang, H.
Medgadget
MAY 2, 2023
While for other patients the possible adverse side effects from medication may prevent them from finding pharmacological therapies effective. Throughout 2016 and until mid-2019 we conducted a deep technology due diligence, as well as market research, and met and spoke with dozens of mental healthcare providers.
Legacy MEDSearch
AUGUST 25, 2022
Despite improvements in patient care pathways, widespread use of reperfusion strategies, and adjuvant pharmacological therapies, the one-year mortality rate after STEMI in high-risk patients has plateaued over the past decade at 14% [1]. The PiCSO Impulse System received ‘Breakthrough Designation’ from the FDA in 2019 and the CE-Mark in 2020.
Expert insights. Personalized for you.
52 
Let's personalize your content